BeiGene, Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $34.64 billion, with shareholders equity totaling $4.76 billion.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, BeiGene, Ltd. reported $5.74 billion in revenue, generating net income of $513.02 million.
Key financial metrics include a P/E ratio of 67.52, a price-to-book (P/B) ratio of 7.28, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ONC.